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Abstract
Background: Dimorphism and biofilm formation are important virulence factors of some opportunistic human
pathogenic yeasts. Such species commensally colonize skin or mucosal surfaces generally in yeast form, but under
particular circumstances, convert into virulent hyphae and disseminate internal organs or cause mucocutaneous
infections. The yeast-to-hypha shape-conversion promotes the development of a biofilm, a thick extracellular matrix
with sessile cells within. The biofilm is capable to prevent the penetration of antifungal drugs, rendering the
surviving biofilm-resident cells intrinsic sources of recurrent infections. The aim of this study was to evaluate the
ability of silver nanoparticles (AgNPs) to attenuate the morphological switch and biofilm formation of several
opportunistic pathogenic yeasts and to determine whether this feature depends on the nanoparticle size.
Results: AgNPs in three different sizes were prepared by chemical reduction approach and characterized by
transmission electron microscopy, ultraviolet–visible spectroscopy and dynamic light scattering. The antifungal
activity was evaluated by the microdilution method, the inhibitory capacity on biofilm formation and the biofilm
degradation ability of differently sized AgNPs was assessed by viability assay. The morphological state of
opportunistic pathogenic yeast cells in monoculture and in co-culture with human keratinocytes in the presence of
AgNPs was examined by flow cytometry and scanning electron microscopy. All the three AgNPs inhibited the
growth of the examined opportunistic pathogenic yeasts, nevertheless, AgNPs with the smallest diameter exhibited
the most prominent toxic activities. AgNPs attenuated the biofilm formation in a nanoparticle size-dependent
manner; however, their biofilm destruction capacity was negligible. AgNPs with the smallest size exerted the most
significant effect on suppressing the morphological change of pathogens in monoculture as well as in a co-culture
with keratinocytes.
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Conclusions: Our results confirm that AgNPs are capable to hinder yeast-to-hypha morphological conversion and
biofilm formation of opportunistic pathogens and this biological effect of AgNPs is size-dependent.
Keywords: Pathogenic yeasts, Silver nanoparticles, Morphological switch, Biofilm formation, Human keratinocytes,
Toxicity
Background
The incidence of human infections caused by yeasts or
other fungi increased worldwide during the last decades,
generating significant health problems [1]. Although the
symptoms of fungal diseases are often mild and superficial
(e.g. irritation, itching and swelling), on occasion, life-
threatening invasive infections develop. The clinical mani-
festations of such infections are strongly related to host im-
munity and to the particular physiological condition of the
patient [2, 3]. Despite antifungal therapy, invasive fungal
diseases are associated with high mortality rate causing the
death of about one and half million people in a year, mainly
due to complications attributed to the infection [4]. Espe-
cially immune-compromised and severely ill patients are at
high risk and exhibit increased susceptibility to systemic
fungal infections [5]. The most common pathogens gener-
ating invasive infections belong to Candida, Cryptococcus,
Aspergillus and Pneumocystis genera; however, several spe-
cies from Lodderomyces, Pichia, Rhodotorula and Trichos-
poron genera have recently been implicated in the
development of systemic infections [6–12].
Numerous factors influence the pathogenic capacity of
the above mentioned species, such as secretion of spe-
cific enzymes, thermotolerance, toxin production, as well
as morphologic transformation [2]. Indeed, several op-
portunistic pathogenic yeasts present dimorphism.
Under certain conditions, these yeast cells experience a
special morphological alteration and turn into elongated
cells called hyphae. It has been shown that such a con-
version is a fundamental feature of the pathophysiology
and the virulence of these strains [13, 14]. As a matter of
fact, opportunistic pathogens commensally colonize the
skin or mucosal surfaces of the gastrointestinal and uro-
genital tracts mostly in yeast form, then yeasts switch to
virulent hyphae which can disseminate internal organs
or cause mucocutaneous infections [15].
Phenotypic switching requires a massive shift in the
gene expression pattern to support the extensive remod-
eling of the cell wall and of the cytoskeleton, and to pro-
duce specific proteins to promote host adhesion and
invasion. For example, hyphae are capable of releasing
hydrolytic enzymes to help them penetrate into the host
tissue more easily, but these filamentous cells can also
assist other, non-dimorphic species upon host invasion
[16]. Therefore, such a morphological switch represents
an important virulence factor of the pathogens.
The yeast-to-hypha shape-conversion also promotes
the development of a biofilm either on inert (medical de-
vices, such as catheters, shunts and stents) or on bio-
logical surfaces, like skin or mucosa [17]. Biofilms are
well-structured communities wherein cells are sur-
rounded by a thick extracellular matrix [18]. Since this
matrix prevents the penetration of drugs, sessile cells
within the biofilms are usually protected from antifungal
agents, thus the surviving biofilm-resident cells are in-
trinsic sources of recurrent infections [19].
The limited number and the moderate or low efficacy
of antifungal drugs, the severe adverse effects related to
their administration and the emergence of resistant
strains are still main challenges in the treatment of fun-
gal diseases, and stressed the need to develop new,
highly effective drugs to combat pathogenic species. Sil-
ver nanoparticles (AgNPs) fulfill such requirements,
since they exhibit outstanding biological activities, such
as anti-cancer, antibacterial, antiviral and antifungal ef-
fects [20–25]. Exploiting these advantageous properties,
the applications of AgNPs are widespread: as disinfecting
materials, in cosmetic industry, wastewater treatment
but also for a broad range of biomedical applications
[20, 26]. As a consequence, there is a huge global de-
mand to increase the production of nanosized silver,
using conventional chemical methods or alternative, en-
vironmentally safe and sustainable, green synthetic ap-
proaches [27–31].
It was demonstrated on different human cell lines and
even on plant and bacterial cells, that the biological ef-
fect of silver nanoparticles depends on the particle size
[32–36]. Although the antifungal activity of AgNPs was
proven on numerous species, the impact of nanoparticle
size on the morphological switch of dimorphic yeasts
has not been addressed yet. Since yeast-to-hypha shift is
a significant virulence factor and is directly related to
biofilm formation, it is fundamental to understand how
the size of AgNPs could affect this feature. Therefore, in
this present study we carried out a complex screening
on selected dimorphic yeasts to determine the size-
dependent effects of AgNPs on morphological change of
these species. For this purpose, we synthesized AgNPs in
three different sizes and treated dimorphic yeasts with
the obtained nanoparticles. The morphology of the cells,
the degree of biofilm development and the viability of
the cells within the biofilm were analyzed after silver
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nanoparticle applications. To evaluate whether the effects
of differently sized AgNPs on yeast-to-hypha switch mani-
fest on biotic surface colonizing species as well, a co-
culture system consisting of human keratinocyte cells and
dimorphic yeasts was established and treated with AgNPs.
Results
Characterization of nanoparticles
Silver nanoparticles in three different sizes were pre-
pared by chemical reduction in a size-controlled, seed-
mediated growth approach and were subsequently char-
acterized by transmission electron microscopy (TEM),
ultraviolet–visible (UV-Vis) spectroscopy and dynamic
light scattering (DLS).
TEM images indicated that all three nanoparticle sam-
ples contained quasi-spherical AgNPs (Fig. 1a). Based on
image analysis only minor polydispersity was observed
and the average size of the AgNPs proved to be 7.0 ± 1.6
nm for AgNP-I, 21.4 ± 4.6 nm for AgNP-II and 50.3 ±
7.9 nm for AgNP-III, respectively. UV-Vis spectra of
AgNPs showed absorption peak maxima at 395 nm in
case of AgNP-I, at 404 nm for AgNP-II and at 442 nm
for AgNP-III, characteristic to surface plasmon reson-
ance, which further supported the formation of metallic
silver nanoparticles and confirmed the difference in
average nanoparticle diameters between the three sam-
ples (Fig. 1b). According to DLS measurements (Fig. 1c),
the average hydrodynamic particle size of AgNP-I was
between 5 and 12 nm diameter, that of AgNP-II was be-
tween 15 and 50 nm, whereas the size of AgNP-III nano-
particles was around 35–90 nm, providing further
evidence of the nanoparticle size difference in the ob-
tained three silver colloid solutions.
Antifungal activity of the differently sized AgNPs
The potential toxic effect of AgNPs with different sizes
was tested against Candida, Lodderomyces and Pichia spe-
cies (Table 1). We found that all three AgNP specimens
inhibited the growth of the examined strains but in a dif-
ferent extent. AgNP-I proved to be the most effective one,
while AgNP-III exerted the least toxic activity. Pichia
membranifaciens CBS 191 was the most susceptible for
Fig. 1 Physicochemical properties of citrate-stabilized silver nanoparticles of three different sizes. Transmission electron microscopic images (a)
and UV-Vis spectra (b) of the synthetized, differently sized AgNPs. Size distribution of the nanoparticles determined by dynamic light scattering
measurements (c)
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the AgNPs as the lowest minimal inhibitory concentra-
tions (MIC) were detected for this strain (Table 2). Unfor-
tunately, in many cases the minimal inhibitory
concentrations could not be established (Table 3) because
of the low concentrations of the AgNP stock solutions.
The effect of AgNPs on biofilm formation and destruction
In order to examine whether AgNPs are capable of modu-
lating the propensity of dimorphic yeasts to build biofilms,
secondly, to test whether the degree of such a modulatory
action would depend on the nanoparticle diameter, we
treated Candida and Lodderomyces cells with differently
sized AgNPs in two concentrations and detected the via-
bility of fungal cells within the biofilms by 2,3-bis-(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-car-
boxanilide (XTT) assay. The higher dose corresponded to
75 μg/mL in case of C. albicans, C. dubliniensis, C. krusei,
C. tropicalis, 37.5 μg/mL for C. parapsilosis and 18.75 μg/
mL for Lodderomyces sp., respectively. The lower dose
was generally set as 18.75 μg/mL, except for Lodderomyces
elongisporus, where it was set to 9.3 μg/mL.
AgNPs exerted inhibitory effect on the biofilm forma-
tion of every examined Candida and Lodderomyces
strain. In most cases the observed repression on biofilm
development was dose- and size-dependent, and gener-
ally, nanoparticles with the smallest average diameter
(AgNP-I) hampered the biofilm formation more effi-
ciently than AgNP-II or AgNP-III solutions (Fig. 2).
Moreover, treatments of the biofilms with AgNPs in
higher concentrations could enhance their inhibitory ef-
fect on biofilm development (Fig. 2). Pichia membranifa-
ciens CBS 191 cells did not adhere to the surface of the
microplates, and did not develop a biofilm suitable for
examination.
As we found that AgNPs inhibited biofilm formation
quite efficiently, next we examined whether AgNPs were
capable to destroy already existing fungal biofilms as
well. The biofilm degradation ability of differently sized
AgNPs was screened using matured biofilms of Candida
and Lodderomyces species. Silver nanoparticles were ap-
plied on biofilms in two concentrations (the same high
and low doses were used as upon biofilm formation ex-
periments). Our results indicated that significant biofilm
degradation could not be achieved using any of these
citrate-stabilized AgNPs. Smaller nanoparticles applied
in high concentration (AgNP-I, 75 μg/mL) were just as
non-effective on the stable fungal biofilm as large AgNPs
(Fig. 3).
Morphology of AgNP-treated strains
Since the generation of elongated cells by yeast-to-hypha
conversion is a prerequisite of biofilm formation by most
dimorphic yeasts, the shape of C. albicans (Fig. 4) cells
treated with differently sized AgNPs were analyzed first
by flow cytometry, then with scanning electron micros-
copy (SEM). Using flow cytometry, the almost spherical
yeasts can be discriminated from the elongated hypha in
the supernatant of the sample, thus the differing mor-
phological states of potentially pathogenic species can be
quantified in suspension. By SEM on the other hand, the
morphology of surface attached individual cells or cells
within the biofilm can be visualized. The percentage of
elongated C. albicans hyphae in the suspension of the
untreated control was 10.2%, whereas in the supernatant
of AgNP-I-treated samples only 2.4% of the cells were in
hypha form. We quantified 5.05% elongated cells in the
AgNP-II-, and 11.3% in the AgNP-III-treated sample su-
pernatants by flow cytometry (Fig. 4a). These results in-
dicate that small sized AgNPs (AgNP-I) were highly
effective in suppressing the morphological conversion of
dimorphic yeasts. On the other hand, the largest AgNPs
Table 1 List of the tested strains
Species Strain number
Candida albicans SC 5314
Candida dubliniensis CBS 7987
Candida krusei CBS 573
Candida parapsilosis CBS 604
Candida tropicalis CBS 94
Lodderomyces elongisporus CBS 1072
Pichia membranifaciens CBS 191
CBS Centraalbureau voor Schimmelcultures, SC Squibb Institute for Medical
Research, New Brunswick, New Jersey, USA
Table 2 Minimal inhibitory concentrations of the synthesized AgNPs against yeasts with pathogenic potential
Species AgNP-I (μg/mL) AgNP-II (μg/mL) AgNP-III (μg/mL)
Candida albicans SC 5314 > 75 > 75 > 75
Candida krusei CBS 573 > 75 > 75 > 75
Candida parapsilosis CBS 604 37.5 > 75 > 75
Candida tropicalis CBS 94 > 75 > 75 > 75
Candida dubliniensis CBS 7987 > 75 > 75 > 75
Lodderomyces elongisporus CBS 1072 37.5 18.75 37.5
Pichia membranifaciens CBS 191 4.6875 18.75 37.5
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(of approx. 50 nm diameter) had no effect on yeast-to-
hypha transformation, as C. albicans cultures exposed to
AgNP-III contained comparable amounts of elongated
hypha forms in the supernatant as the untreated control.
SEM images taken of AgNP-treated and untreated C.
albicans cells (Fig. 4b) confirmed the morphological dif-
ferences determined by flow cytometry. Mostly yeast
forms were found in the AgNP-I-exposed samples, how-
ever, shorter or longer hyphae appeared in samples treated
with AgNP-II and AgNP-III (representative images are
shown in Fig. 4b). SEM images revealed massive biofilm
formation in untreated C. albicans samples, where almost
exclusively elongated hyphae were present. These results
suggest that small-sized silver nanoparticles (AgNP-I) ex-
hibit the highest potential to suppress yeast-to-hypha mor-
phological switch of the opportunistic pathogenic yeast
strains. Moreover, our data indicate that with increasing
nanoparticle diameters the capacity of AgNPs to inhibit the
morphological switch of dimorphic fungi decreases
substantially.
Since the inhibition of morphological switch can be
the consequence of oxidative stress induced by AgNP
treatments, we investigated the reactive oxygen species
(ROS) generating potential of differently sized AgNPs in
C. albicans cultures. Cells were treated with AgNP-I,
AgNP-II and AgNP-III, respectively, and were stained
with 2′,7′–dichlorofluorescein diacetate (DCFDA). 2′,
7′–dichlorofluorescein (DCF) fluorescence intensity
values show that small-sized AgNPs (AgNP-I) induce
significant ROS production compared to untreated con-
trol samples, however, medium-sized AgNPs are less
Fig. 2 Inhibitory effect of differently sized AgNPs on biofilm formation of opportunistic pathogenic yeasts. Inhibitory effect of AgNPs on the
formation of biofilms was evaluated by determining the viability of the various Candida and Lodderomyces cells in the biofilm using XTT assay
after 72-h treatments with AgNP-I, AgNP-II or AgNP-III in the indicated concentrations. Suspensions without AgNPs were used as growth control.
The values represent the mean ± standard deviation calculated from three independent experiments (*, p ≤ 0.05, **, p ≤ 0.01, ***, p≤ 0.001, ****,
p≤ 0.0001, unpaired t test)
Table 3 The inhibition rate (%) in the presence of differently
sized AgNPs applied in 75 μg/mL concentration
Species AgNP-I AgNP-II AgNP-III
Candida albicans SC 5314 75 50 25
Candida krusei CBS 573 90 90 10
Candida parapsilosis CBS 604 100 90 65
Candida tropicalis CBS 94 90 40 40
Candida dubliniensis CBS 7987 60 20 0
Lodderomyces elongisporus CBS 1072 100 100 100
Pichia membranifaciens CBS 191 100 100 100
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potent and AgNP-III is a very weak inducer of ROS gen-
eration (Fig. 4c). Hence, the different degree of oxidative
stress triggered by differently sized AgNPs can form the
molecular basis for the morphology switch inhibiting po-
tential of AgNPs in C. albicans cells.
Efficiency of AgNPs to modulate the morphological switch
of opportunistic pathogenic yeasts on biotic surfaces
The effects of differently sized AgNPs on yeast-to-hypha
switch of opportunistic pathogenic yeasts were then deter-
mined in a co-culture system, consisting of human keratino-
cyte cells and dimorphic yeasts, generated with the aim to
model fungal infection on biotic surfaces, like human skin.
First, the toxicity of the synthesized silver colloids was
assessed on human HaCaT keratinocytes by 3-(4,5-di-
methylthiazol-2-yl)-2,5 diphenyl tetrazolium bromide
(MTT) viability assay. As expected, AgNPs decreased
cell viability in size-, and concentration-dependent man-
ner. The calculated half maximal inhibitory concentra-
tion (IC50) values indicated that the strongest toxicity on
human keratinocytes was achieved upon small nanopar-
ticle (AgNP-I) exposures (IC50 = 8.02 ± 1.7 μg/mL), while
lower extent of cell death was induced by medium-sized
AgNPs (AgNP-II, IC50 = 42.6 ± 18.3 μg/mL). The smallest
decrease in viability was detected following AgNP-III
nanoparticle treatments (IC50 = 91.3 ± 6.1 μg/mL).
Then, co-cultures of HaCaT human keratinocytes and
C. albicans cells (in 1:5 human/yeast cell ratio) were
established, and exposed to differently sized AgNPs in
75 μg/mL concentration for 8 h. During treatment hypha
formation of Candida cells was followed microscopic-
ally. C. albicans cells were present in filamentous form
in the untreated co-cultures, and after 8-h incubation a
thick biofilm could be observed over and around kerati-
nocytes (Fig. 5). AgNP treatments clearly reduced hypha
formation of C. albicans, since less elongated cells were
found in AgNP-exposed cultures after 4 and 8 h incuba-
tion, compared to the corresponding untreated control.
Importantly, inhibition of the yeast-to-hypha switch in
the co-culture proved to be nanoparticle size-dependent.
We noticed that AgNP-I administration attenuated
hypha formation as well as the biofilm generation of C.
albicans with the highest degree on the surface of the
keratinocyte layer. This inhibitory effect was smaller
when AgNP-II was applied, and resulted to be the least
pronounced upon AgNP-III administration (Fig. 5). SEM
images taken from AgNP-treated C. albicans and HaCaT
keratinocyte cells in the co-culture supported the above
Fig. 3 Effect of differently sized AgNPs on biofilm degradation. To determine the ability of AgNPs to destroy existing biofilms, three-day old
matured biofilms of Candida and Lodderomyces strains were treated for 72 h with differently sized AgNPs in the indicated concentrations and the
viability of the cells was assessed by XTT assay. The values represent the mean ± standard deviation calculated from three
independent experiments
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described morphological differences (Fig. 5). It is import-
ant to note that throughout the co-culture experiments,
also upon AgNP treatments (8-h incubation of the co-
cultures with AgNPs was monitored microscopically)
keratinocyte morphology, the integrity of HaCaT cell
layer as well as cell-cell contacts were not compromised.
All these results indicate that the morphological switch
of dimorphic, potentially pathogenic fungal cells can be
attenuated by AgNPs not only on abiotic, but also on bi-
otic surfaces such as skin, and smaller particle diameters
are more advantageous to suppress the formation of
virulent hyphae.
Discussion
Morphological plasticity, such as the capability to
undergo a yeast-to-hypha transformation, contributes
Fig. 4 Morphology of control and AgNP-treated C. albicans cells. Cell morphology of untreated and AgNP-exposed C. albicans was detected by
flow cytometry after 72-h incubation in the presence of differently sized AgNPs in 75 μg/mL concentration. The percentage of aggregated, yeast-
shaped and elongated cells were quantified by IDEAS 6.2 software (Amnis-EMD Millipore, Burlington, MA, USA) and the percentage of elongated
cells is indicated on the figures (a). Morphology of the surface-anchored cells after 72-h incubation in the presence of AgNPs was analyzed using
scanning electron microscopic images (b). In order to assess the degree of reactive oxygen species formation, mean DCF fluorescence intensity
was determined on DCFDA-stained, AgNP-treated C. albicans cells. Values represent the mean ± standard deviation calculated from three
independent experiments (****, P < 0.0001, unpaired t test) (c)
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significantly to the virulence of many opportunistic hu-
man pathogenic yeasts. In response to the changing en-
vironmental conditions within the host, planktonic yeast
cells convert to filamentous hyphae, and the emerging
elongated cells facilitate the pathogen penetration and
potentiate host invasion [37]. Filament formation is also
an indispensable factor for the generation of structured
microbial communities called biofilm. Hyphae provide
the structural integrity and the multilayered architecture
for mature biofilms [38]. Biofilm-located cells express
decreased sensitivity to antifungal compounds compli-
cating the treatment of fungal diseases. Therefore, the
inhibition of the morphological switch and thereby bio-
film development could decrease the virulence of these
pathogens and promotes the eradication of the infection.
The antiseptic application of silver goes back to an-
cient times, however, the emergence of various antibi-
otics confined its usage substantially [39]. In the last two
decades, silver has been re-introduced to broad range
medical applications in the nanoparticle formulation.
AgNPs perform well against numerous Gram-positive
and Gram-negative bacteria, several viruses and patho-
genic fungi as well. The mechanism of action behind the
anti-pathogenic activity of AgNPs has not been eluci-
dated in every detail. Nevertheless, it is generally ac-
cepted that AgNPs exert their antimicrobial effects
through microbial membrane damage, caused by the at-
tachment of AgNPs on the cell surface, which leads to
structural as well as functional alterations in the mem-
brane (membrane destabilization, formation of pores
and cytoplasm leakage). This action is complemented by
the release of Ag+ ions from the nanoparticle surface,
which provokes the generation of reactive oxygen spe-
cies [39]. The latter will ultimately induce sub-cellular
structure damage by inactivation and denaturation of es-
sential microbial macromolecules (proteins, enzymes,
and nucleotides) and leads to apoptotic cell death [40].
Although innovative AgNP synthesis methods emerge
daily, and the as-prepared nanomaterials are now rou-
tinely tested for cytotoxic, antibacterial or antifungal ac-
tivities [41–43], the scientific literature is scarce in
reports describing the effects of AgNPs on yeast cell
ultrastructure and biofilm development. In fact, only a
few authors examined the AgNP-induced morphological
changes of Candida albicans. They demonstrated that
silver nanoparticles hamper C. albicans biofilm forma-
tion in vitro via inhibition of filament formation and by
destruction and of the cell wall integrity. Lara and co-
workers applied extremely small, in average 1 nm sized
AgNPs on C. albicans cells [38], whereas Muthamil
et al. used relatively big (40–55 nm) AgNPs [44], and fi-
nally, Jalal et al. utilized polydispersed biosynthesized
Fig. 5 Size-dependent modulation of the morphological switch of opportunistic pathogenic yeasts co-cultured with keratinocytes by AgNPs.
Morphology of C. albicans cells in co-culture with keratinocytes was monitored by light microscopy after 4 and 8 h, as well as by scanning
electron microscopy after 8 h of AgNP-I, AgNP-II and AgNP-III treatments
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AgNPs [45]. However, none of these studies investigated
the size-dependent effect of the AgNPs on this species,
nor tested the actions of AgNPs on dimorphic yeasts of
other genus.
Therefore, in the present work we studied the size-
dependent action of silver nanoparticles on the morpho-
logical transition and subsequent biofilm formation of dif-
ferent dimorphic yeast species. To achieve this aim citrate-
coated AgNPs in three different sizes (AgNP-I: ~ 7.0 nm;
AgNP-II: ~ 21 nm; AgNP-III: ~ 50 nm) were successfully
prepared by one of the most widely utilized chemical re-
duction approaches [46]. The sizes of the different AgNP
samples were verified by TEM and DLS measurements.
UV-Vis spectra of the prepared colloids also supported the
synthesis of AgNPs based on previously reported spectral
characteristics of particles with similar morphologies [47].
The antifungal activity test revealed that silver nanoparticles
with the smallest size (AgNP-I) were the most effective
against the examined opportunistic pathogenic species. C.
parapsilosis and rare pathogens such as L. elongisporus and
P. membranifaciens proved to be the most sensitive to
AgNP exposures [48].
Importantly, biofilm development of the Candida spe-
cies and L. elongisporus was substantially inhibited in the
presence of the nanoparticles, and in this respect again
AgNP-I proved to be the most potent, as treatments
with small nanoparticles led to the most significant de-
cline in the viability of biofilm-located cells. The strong
capacity of small AgNPs to inhibit biofilm formation
correlated well with the attenuated hypha formation of
AgNP-I-exposed dimorphic yeasts, demonstrated by
FACS and SEM data. Most probably the formation of re-
active radicals and the consequent oxidative stress in-
duced by small AgNPs lay behind this outstanding
potential of small-sized nanoparticles to hamper mor-
phological switch in dimorphic yeasts.
The observed inhibitory feature of AgNPs on yeast-to-
hypha morphological conversion holds great potential in
nanomedicine, if this ability of AgNPs manifests on bio-
logical surfaces. Therefore, we tested the capability of
AgNPs to suppress the morphological transformation of
C. albicans in a co-culture system with human keratino-
cytes. As before, considerably decreased hypha formation
was detected in the presence of AgNP-I compared to
untreated control cultures. These results suggest that
the capability of AgNPs, especially those with small di-
ameters, to modulate the morphological transformation
and thereby the virulence of dimorphic pathogenic
yeasts is maintained on biotic surfaces, like skin and mu-
cosa, which feature can be exploited further in biomed-
ical applications. On the other hand, it is important to
note, that in contrast to the findings by Lara et al. [38],
in our study AgNPs could not disintegrate already devel-
oped, matured biofilms, since we found that the biofilm
destruction ability of the differently sized, citrate-coated
AgNPs was negligible. Our findings imply the prophylac-
tic application of citrate-coated AgNPs in order to take
advantage of their antifungal capacities against di-
morphic yeasts.
Normally, a sequence of tightly regulated events leads to
successful biofilm generation. Yeast cells colonize and ad-
here to soft or hard surfaces mediated by specific adhesion
factors. In case of C. albicans, key regulators, like Bcr1, as
well as its downstream targets such as cell wall proteins
Als1, Als3 have been implicated as required elements for
the early steps of the process [49]. Cell-cell communica-
tion, especially quorum sensing, is also crucial at this stage
to prevent overpopulation and competition for nutrients,
and for the induction of hypha-formation-associated
genes. After initial adherence and focal attachment of in-
dividual cells, a basal layer is formed, which is then sub-
jected to cell proliferation, early-stage filamentation,
followed by the production of exopolymeric substance by
sessile cell communities in the multilayered network regu-
lated by factors like Rlm1 and Zap1 in C. albicans [49].
Exposure of dimorphic fungi to AgNPs and the produced
reactive radicals might affect most of these events, never-
theless, the precise mechanisms at the molecular level be-
hind the inhibitory action of AgNPs on the morphological
switch and biofilm formation of these opportunistic path-
ogens is yet to be demonstrated. In fact, we have already
started to establish a set of mutant Candida strains for
testing which molecular event related to morphological
conversion is perturbed by AgNP exposures or by the trig-
gered oxidative stress.
Our results indicate that virulence factors of opportunistic
pathogens, like morphological switch and biofilm formation
can be efficiently modulated by the utilization of AgNPs.
However, it has to be stressed that in order to achieve the
desired effects, nanomaterials have to be designed properly.
We found that size indeed matters when AgNPs are
intended to act on dimorphic pathogenic yeasts. The per-
formance of larger nanoparticles (AgNP-III) in impairing
yeast-to-hypha conversion and biofilm generation was con-
siderably worse than medium (AgNP-II) and small-sized
(AgNP-I) counterparts, which phenomenon might be ex-
plained by their different abilities in ROS production. Since
AgNP size seems to have a defining role in determining and
fine-tuning the biological activity of nanoparticles, hence,
more careful considerations are required upon nanomaterial
design and production and thorough screening regimens of
the obtained nanomaterials are recommended to estimate
their efficiencies.
Conclusions
Our data confirm that citrate-coated AgNPs are able to
inhibit the morphological switch and biofilm formation
of dimorphic yeasts, however, they are not effective
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against fully developed biofilms. AgNPs with the smal-
lest size performed especially well in all experiments fur-
ther supporting the fact that particle size has significant
impact on the biological activity of these nanomaterials.
Our results might influence potential strategies and op-
portunities for the clinical translation of AgNP applica-
tion in the field of medical mycology.
Methods
Synthesis of silver nanoparticles
All chemicals for the nanoparticle synthesis were ob-
tained from Merck (Darmstadt, Germany).
Citrate-stabilized silver nanoparticles in three different
sizes were prepared by chemical reduction using sodium
borohydride, according to Wan et al. with slight adjust-
ments [46]. Twenty mL of 1% w/v citrate solution and 75
mL of water were added in a beaker and the mixture was
heated to 70 °C. Then, 2mL of 1% w/v AgNO3 solution
were introduced to the mixture, followed by drop-wise
addition of 2 mL of 0.1% w/v freshly prepared sodium bo-
rohydride solution. The reaction solution was kept at
70 °C under vigorous stirring for 1 h and was then cooled
to room temperature. The resulting AgNPs, denoted as
AgNP-I, were used as starter seeds for AgNP-II.
To obtain larger AgNPs in a size-controlled manner, a
seed-mediated growth approach was employed. For the
synthesis of AgNP-II with an average diameter of 20 nm,
2 mL of 10% w/v citrate solution was mixed with 75mL
of water and brought to 80 °C. Next, 10 mL of starter
seed solution (AgNP-I) were added, followed by the sup-
plementation of 2 mL of 1% w/v AgNO3 solution while
vigorous mechanical stirring for 2 h, then the resulting
suspension was cooled to room temperature.
For the production of AgNP-III with an average size of
50 nm, the 20 nm AgNPs (AgNP-II), obtained in the pre-
vious synthesis procedure, were used as seeds, and the
above described growth procedure steps were repeated.
The final colloid samples were stored at 4 °C in all cases.
After synthesis, the nominal concentrations of the
three AgNP samples were about 128 μg/mL, 157 μg/mL
and 160 μg/mL, respectively. For an easier handling
throughout the experiments, we decided to set the con-
centration of all three samples to 150 μg/mL. Concen-
trating AgNP-I was achieved by placing the sample in a
drying oven on 40 °C overnight, then measuring its vol-
ume and adding distilled water if necessary, to get a final
volume of about 85 mL. The latter two samples after
similar procedures were diluted to 93 and 95mL final
volume respectively, thus the standard 150 μg/mL con-
centration for all three samples was achieved. The calcu-
lations (see supplementary material) show how the
nominal concentrations could be assessed for each sam-
ple and the V150 values highlight the final volume of the
standardized AgNP samples that were used for the sub-
sequent in vitro experiments.
Characterization of nanoparticles
The morphological characteristics of AgNPs were exam-
ined by transmission electron microscopy applying a FEI
Tecnai G2 20× microscope (FEI Corporate Headquar-
ters, Hillsboro, OR, USA) at an acceleration voltage of
200 kV. The optical properties of nanoparticles were
assessed by spectral analysis, where the absorbance spec-
tra of nanoparticles were recorded using an Ocean Op-
tics 355 DH-2000-BAL UV–Vis spectrophotometer
(Halma PRC, Largo, FL, USA) within the 300–800 nm
range. The size distribution of the nanoparticle samples
was examined by DLS analysis using a Zetasizer Nano
ZS Instrument (Malvern, Worcestershire, UK).
Antifungal activity
The antifungal susceptibility test was carried out using
the three differently sized silver nanoparticles (AgNP-I,
AgNP-II and AgNP-III) on each potentially pathogenic
yeast species listed in Table 1. The minimal inhibitory
concentration (MIC) was determined with the microdi-
lution method in 96-well microplates. To 50 μL of stan-
dardized cell suspension (5 × 104 cell/mL in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with
1% fetal bovine serum (FBS) 50 μL silver nanoparticle
solution was added in serially two-fold-diluted concen-
trations (in the range of 75 and 4.69 μg/mL in the above
described medium) and incubated for 48 h at 30 °C
(20 °C in the case of Pichia membranifaciens). All Can-
dida and Lodderomyces species grow well at 30 °C, how-
ever, the growth of C. parapsilosis and Lodderomyces
elongisporus is somewhat hampered at 37 °C. Thus, for
this experiment 30 °C incubation temperature was ap-
plied to establish the MIC values in vigorously growing
cultures. The control samples contained 50 μL cell sus-
pension and 50 μL medium without nanoparticles. The
optical density of the cultures was detected at 620 nm in
SPECTROstar Nano plate reader (BMG LabTech, Offen-
burg, Germany). The experiments were carried out at
least three times always in triplicates.
Effect of AgNPs on biofilm formation
The biofilm formation and the viability of the cells in
the biofilm were tested after AgNP treatments. Briefly,
suspensions from each strain in 5 × 104 cell/mL density
were prepared in DMEM medium supplemented with
1% FBS. Then, 50 μL of the cell suspension were trans-
ferred into wells of a microtiter plate and 50 μl of either
AgNP-I, AgNP-II or AgNP-III were added in 75 (high
dose) or in 18.7 μg/mL (lower dose) concentrations, re-
spectively. In some cases where preliminary experimen-
tal results indicated high susceptibility, the AgNP
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concentrations corresponding to high dose and/or low
dose were set differently. Therefore, 37.5 and 18.7 μg/
mL were applied for C. parapsilosis and 18.7 and 9.3 μg/
mL concentrations for L. elongisporus. Suspensions with-
out AgNPs were used as growth control, while the
medium without cells and without AgNPs was used as
negative control. Plates were incubated for 72 h at 37 °C
in 5% CO2 level, then the biofilms were washed twice
with phosphate buffered saline (PBS) to remove slightly
attached cells and 2,3-bis-(2-methoxy-4-nitro-5-sulfo-
phenyl)-2H-tetrazolium-5-carboxanilide (XTT) reduc-
tion assay was used to detect the viability of the biofilm-
associated cells. XTT was prepared at 0.5 mg/mL con-
centration in PBS supplemented with 1 μM menadion.
After adding 100 μL XTT solution to each well, the
plates were incubated for 2 h at 37 °C in dark. There-
after, 80 μL of each supernatant were transferred to new
96-well plates and the absorbance of each solution was
measured at 490 nm using SPECTROstar Nano plate
reader (BMG LabTech, Offenburg, Germany). The ex-
periments were carried out three times always in 8 bio-
logical replicates.
Determination of biofilm degradation ability
The biofilm formation was initiated by inoculating 100–
100 μL cell suspensions (prepared in DMEM medium
supplemented with 1% FBS in 5 × 104 cell/mL density)
from each strain into the wells of flat-bottomed 96-well
microtiter plates. Plates were incubated for 72 h at 37 °C
in an atmosphere containing 5% CO2. After biofilm for-
mation, the medium was removed and silver nanoparti-
cle solutions (diluted in DMEM medium) were added to
the biofilms in 75 or 18.7 μg/mL final concentrations.
For C. parapsilosis, high dose corresponded to 37.5 μg/
mL while low dose was 18.7 μg/mL concentration and in
case of L. elongisporus 18.7 and 9.3 μg/mL concentra-
tions were set as high and low dose. Then plates were
further incubated for 72 h at 37 °C. A series of only
DMEM-treated biofilms and biofilm-free wells contain-
ing DMEM medium served as positive and negative con-
trols. Viability of the cells was detected by XTT
reduction assay, as described above. All the assays were
carried out three times in 8 replicates.
Morphological characterization of fungal cells
C. albicans was selected for morphological analysis of
cells treated with differently sized AgNPs. C. albicans
cells were inoculated into DMEM medium supple-
mented with 1% FBS in 5 × 104 cell/mL concentration
and were cultured for 24 h at 37 °C in the absence, as
well as in the presence of either AgNP-I, AgNP-II or
AgNP-III particles in 75 and 18.75 μg/mL final concen-
trations. The proportion of yeast cells and hyphae was
determined from the sample supernatant by flow
cytometry (FlowSight®, Amnis-EMD Millipore, Burling-
ton, MA, USA). Cells cultured without AgNPs were used
as control.
Detection of reactive oxygen species
ROS production upon AgNP treatments was detected by
DCFDA staining. C. albicans cells were inoculated into
DMEM medium supplemented with 1% FBS in 5 × 104
cell/mL concentration and were cultured for 24 h at 37 °C
in the absence, as well as in the presence of either AgNP-
I, AgNP-II or AgNP-III particles of 75 μg/mL final con-
centrations. Cells cultured with H2O2 in 0.08% concentra-
tion were used as positive control. After the treatments all
cultures were incubated with DMEM containing 10 μM
DCFDA (Sigma-Aldrich) in the dark for 1 h. The total
fluorescence intensity of the samples was measured by
flow cytometry (FlowSight®, Amnis-EMD Millipore,
Burlington, MA, USA). Measurements were repeated
three times using 3 independent biological replicates.
Keratinocyte cell culture
HaCaT immortalized human keratinocyte cells were
purchased from ATCC (Manassas, VA, USA) and main-
tained in DMEM medium containing 4.5 g/L glucose
(Sigma-Aldrich, Saint Louis, MO, USA), supplemented
with 10% FBS, 2 mM L-glutamine, 0.01% streptomycin
and 0.005% penicillin (Sigma-Aldrich, Saint Louis, MO,
USA). Cells were cultured in a 37 °C incubator at 5%
CO2 in 95% humidity.
Measurement of keratinocyte viability
HaCaT cell viability was measured after AgNP-I, AgNP-
II and AgNP-III treatments. For this HaCaT cells were
seeded into 96-well plates in 10,000 cells/well density,
and treated on the following day with silver nanoparti-
cles of three different sizes in increasing concentrations.
After 24-h treatments, HaCaT cells were washed with
PBS and incubated for an hour at 37 °C with 0.5 mg/mL
MTT reagent (SERVA, Heidelberg, Germany) diluted in
culture medium. Formazan crystals were solubilized in
DMSO (Sigma-Aldrich, Saint Louis, MO, USA) and ab-
sorption was measured at 570 nm using a Synergy HTX
plate reader (BioTek-Hungary, Budapest, Hungary). Ex-
periments were performed at least three times using four
independent biological replicates. IC50 values were ob-
tained based on the results of MTT assays.
Co-culture system
HaCaT immortalized human keratinocyte cells were
used in a co-culture system together with C. albicans
cells in order to model fungal infection of human skin.
To investigate the hyphae formation of yeast cells within
co-cultures upon AgNP treatments, HaCaT cells were
seeded into 6-well plates and left to grow until they
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reached confluence to provide a continuous, consistent
biosurface. Then, when this biofilm layer was completely
established, 5 × 105 C. albicans cells were added to the
wells, and the co-cultures were exposed to 75 μg/mL
AgNPs. The cultures were continuously monitored
under the microscope, throughout the investigation
period (maximum 8 h). Photographs were taken after 0;
4; and 8-h treatments using Nikon Eclipse TS100
inverted light microscope (Nikon, Minato, Japan).
Scanning electron microscopy
A.: The ultrastructure of the AgNP-treated and non-
treated C. albicans biofilms formed on sterile glass
coverslips (Sigma-Aldrich, Saint Louis, MO, USA)
was examined by scanning electron microscopy.
Biofilm formation was carried out as described
above in the related Methods section. Cell suspen-
sions were treated with either AgNP-I, AgNP-II or
AgNP-III in 75 μg/mL concentration for 72 h at
37 °C, then cells were washed with PBS and fixed in
2.5% glutaraldehyde at 4 °C overnight.
B.: SEM images were taken of untreated as well as of
AgNP-treated HaCaT - C. albicans co-cultures. For this,
HaCaT cells were seeded onto plastic coverslips (Sar-
stedt, Nümbrecht, Germany) placed in 6-well plates.
On the following day 5 × 105 C. albicans yeast cells were
added to each well and the co-cultures were treated
with differently sized AgNPs in 75 μg/mL concentration.
After 8 h of treatment, cells were washed with PBS and
fixed in 2.5% glutaraldehyde at 4 °C overnight.
All samples (prepared as described in part A or B)
were dehydrated by increasing percentage of ethanol di-
luted in water (50, 70, 80, 90, 95, 98, 100%, for 15 min
each), followed by a series of tert-butanol:ethanol mix-
ture (1:2, 1:1, 2:1 volume ratio) at room temperature.
Then the cells were incubated with absolute tert-butanol
overnight at 4 °C and were finally lyophilized. The cover-
slips were mounted on specimen stubs with electrically
conductive adhesive tape and the samples were covered
with a thin metal palladium-gold layer. SEM imaging
was performed by a Hitachi S4700 electron microscope
(AuroScience, Budapest, Hungary) using 10 kV acceler-
ating voltage and 10 μA emission current.
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